Method for Obtaining Pancreatic Progenitor Cells and Pancreatic Islet Beta Cells By Means of Differentiation of Human Pluripotent Stem Cells
20220186188 · 2022-06-16
Assignee
Inventors
Cpc classification
C12N2501/16
CHEMISTRY; METALLURGY
C12N5/0678
CHEMISTRY; METALLURGY
C12N2506/45
CHEMISTRY; METALLURGY
International classification
Abstract
Provided is a method for obtaining pancreatic precursor cells and islet β cells by differentiation of human pluripotent stem cells by adding a WNT signaling pathway inhibitor into the process of specialization of endoderm cells derived from human pluripotent stem cells into pancreatic lineage cells.
Claims
1: A method of obtaining pancreatic progenitor cells and pancreatic islet β cells by differentiating human pluripotent stem cells, wherein the method comprises the following steps: 1) differentiating the human pluripotent stem cells into definitive endoderm cells, comprising: a. preparing definitive endoderm stage medium 1, and culturing the human pluripotent stem cells in the medium in a carbon dioxide incubator at 37 degrees Celsius for 1 day; and b. preparing definitive endoderm stage medium 2, replacing the definitive endoderm stage medium 1 in mentioned-above step a with the definitive endoderm stage medium 2, and culturing the cells in a carbon dioxide incubator at 37 degrees Celsius for 3 days, during which the medium is replaced every day, wherein the composition of the definitive endoderm stage medium 1 is: an IMDM medium and an F12 medium mixed at a ratio of 1:1 as a basic medium, and further comprising the following components at working concentrations of: 0.2% of bovine serum albumin (BSA), 1% of penicillin, 1% of streptomycin, 100 ng/ml of recombinant human activin-A (Activin A), and 50 ng/ml of Wnt3a protein, with the working concentrations all being final concentrations; and wherein the composition of the definitive endoderm stage medium 2 is: the IMDM medium and the F12 medium mixed at a ratio of 1:1, and further comprising the following components at the working concentrations arc of: 0.2% of bovine serum albumin (BSA), 1% of penicillin, 1% of streptomycin, and 100 ng/ml of recombinant human activin-A (Activin A), with the working concentrations all being final concentrations; 2) inducing differentiation of definitive endoderm cells into pancreatic progenitor cells, comprising: preparing a pancreatic progenitor cell medium, replacing the medium in step 1) with the pancreatic progenitor cell medium, and culturing the cells in a carbon dioxide incubator at 37 degrees Celsius for 5 days, during which the medium is replaced every day, wherein the composition of the pancreatic progenitor cell medium is: an MCDB131 medium as a basic medium, and further comprising the following components at the working concentrations of: 0.5% of bovine serum albumin (BSA), 1.5 g/L of sodium bicarbonate, 1×glutamine (GlutaMAX), 10 mM glucose, 0.25 M vitamin C, 1×insulin-transferrin-selenium-ethanolamine additive (ITS-X), 50 ng/ml of fibroblast growth factor 7 (KGF), 0.5 μM SANT1 (with smo as an inhibitor target), 100 nM retinoic acid (TTNPB), 500 nM phorbol 12,13-dibutyrate (PDBu), 2 μM ALK inhibitor (K02288), and a WNT signaling pathway inhibitor, with the working concentrations all being final concentrations; and 3) differentiating further the pancreatic progenitor cells to obtain pancreatic islet β cells, comprising: a. preparing pancreatic islet β cell medium 1, replacing the medium in step 2) with the pancreatic islet β cell medium 1, and culturing the cells in a carbon dioxide incubator at 37 degrees Celsius for 5 days, during which the medium is replaced every day; and b. preparing pancreatic islet β cell medium 2, replacing the pancreatic islet β cell medium 1 in the above-mentioned step a with the pancreatic islet β cell medium 2, and culturing the cells in a carbon dioxide incubator at 37 degrees Celsius for 5 days, during which the medium is replaced every day, wherein the composition of the pancreatic islet β cell medium 1 is: the MCDB131 medium as the basic medium, and further comprising the following components at the working concentrations of: 20 mM glucose, 2% of bovine serum albumin (BSA), 1.5 g/L of sodium bicarbonate, 1×glutamine (GlutaMAX), 0.05 mM vitamin C, 1×insulin-transferrin-selenium-ethanolamine additive (ITS-X), 2 μM ALK inhibitor (K02288), 1 μM triiodothyronine (T3), 10 μM YO-01027 (Notch signaling pathway inhibitor), and 10 μM zinc sulfate, with the working concentrations all being final concentrations; and wherein the composition of the pancreatic islet β cell medium 2 is: the MCDB131 medium as the basic medium, and further comprising the following components at the working concentrations of: 20 mM glucose, 2% of bovine serum albumin (BSA), 1.5 g/L of sodium bicarbonate, 1×glutamine (GlutaMAX), 0.05 mM vitamin C, 1×insulin-transferrin-selenium-ethanolamine additive (ITS-X), 1 μM triiodothyronine (T3), 10 μM Repsox (ALK5 inhibitor), 10 μM vitamin E, 10 μg/ml of heparin sodium, 2 μM R428 (Axl inhibitor), 10 μM zinc sulfate, and 10 mM N-acetyl-L-cysteine (N-cys), with the working concentrations all being final concentrations.
2: The method according to claim 1, wherein the human pluripotent stem cells are human embryonic stem cells.
3: The method according to claim 1, wherein the human pluripotent stem cells are human induced pluripotent stem cells.
4: The method according to claim 2, wherein the WNT signaling pathway inhibitor in step 2) is XAV-939 or IWR-1.
5: The method according to claim 3, wherein the WNT signaling pathway inhibitor in step 2) is XAV-939.
6: The method according to claim 1, wherein the concentration of the WNT signaling pathway inhibitor in step 2) is 2 μM.
Description
BRIEF DESCRIPTION OF DRAWINGS
[0028]
[0029]
[0030]
[0031]
[0032]
[0033]
[0034]
[0035]
[0036]
[0037]
[0038]
[0039]
[0040]
[0041]
[0042]
[0043]
DETAILED DESCRIPTION
[0044] The present disclosure is further described below with the accompanying drawings and specific embodiments, and the embodiments are only illustrative of the method, and do not limit the rest content disclosed by the present invention in any way.
[0045] Unless otherwise specified, the test methods in the following embodiments are all conventional methods.
[0046] Unless otherwise specified, the materials, reagents, etc. in the following embodiments can all be obtained from commercial sources.
Example 1 Differentiation of Human Embryonic Stem Cells into Pancreatic Progenitor Cells and Mature Pancreatic Islet β Cells by Induction of the WNT Signaling Pathway Inhibitor XAV-939
[0047] (1) Cell Differentiation
[0048] 1) Differentiation of Human Embryonic Stem Cells into Definitive Endoderm Cells:
[0049] a. definitive endoderm stage medium 1 was prepared, and the human embryonic stem cells were cultured in the medium in a carbon dioxide incubator at 37 degrees Celsius for 1 day; and
[0050] b. definitive endoderm stage medium 2 was prepared, the definitive endoderm stage medium 1 in above-mentioned step a was replaced with the definitive endoderm stage medium 2, and the cells were cultured in a carbon dioxide incubator at 37 degrees Celsius for 3 days, during which the medium was replaced every day, wherein the composition of the definitive endoderm stage medium 1 was: an IMDM medium and an F12 medium were mixed at a ratio of 1:1 as a basic medium, and the following components at the working concentrations were further included: 0.2% of bovine serum albumin (BSA), 1% of penicillin, 1% of streptomycin, 100 ng/ml of recombinant human activin-A (Activin A), and 50 ng/ml of Wnt3a protein, with the concentrations all being final concentrations; and the composition of the definitive endoderm stage medium 2 was: an IMDM medium and an F12 medium were mixed at a ratio of 1:1 as a basic medium, and the following components at the working concentrations were further included: 0.2% of bovine serum albumin (BSA), 1% of penicillin, 1% of streptomycin, and 100 ng/ml of recombinant human activin-A (Activin A), with the concentrations all being final concentrations.
[0051] 2) Induction of the Differentiation of Definitive Endoderm Cells into Pancreatic Progenitor Cells:
[0052] a pancreatic progenitor cell medium was prepared, the medium in step 1) was replaced with the pancreatic progenitor cell medium, and the cells were cultured in a carbon dioxide incubator at 37 degrees Celsius for 5 days, during which the medium was replaced every day, wherein the composition of the pancreatic progenitor cell medium was: with an MCDB131 medium as a basic medium, and the following components at the working concentrations were further included: 0.5% of bovine serum albumin (BSA), 1.5 g/L of sodium bicarbonate, 1×glutamine (GlutaMAX), 10 mM glucose, 0.25 M vitamin C, 1×insulin-transferrin-selenium-ethanolamine additive (ITS-X), 50 ng/ml of fibroblast growth factor 7 (KGF), 0.5 μM SANT1 (with smo as an inhibitor target), 100 nM retinoic acid (TTNPB), 500 nM phorbol 12,13-dibutyrate (PDBu), 2 μM ALK inhibitor (K02288), and 2 μM WNT signaling pathway inhibitor XAV-939 (not added in a control group), with the concentrations all being final concentrations.
[0053] 3) Further Differentiation of Pancreatic Progenitor Cells to Obtain Pancreatic Islet β Cells:
[0054] a. pancreatic islet β cell medium 1 was prepared, the medium in step 2) was replaced with the pancreatic islet β cell medium 1, and the cells were cultured in a carbon dioxide incubator at 37 degrees Celsius for 5 days, during which the medium was replaced every day; and
[0055] b. pancreatic islet β cell medium 2 was prepared, the pancreatic islet β cell medium 1 in above-mentioned step a was replaced with the pancreatic islet β cell medium 2, and the cells were cultured in a carbon dioxide incubator at 37 degrees Celsius for 5 days, during which the medium was replaced every day, wherein the composition of the pancreatic islet β cell medium 1 was: with an MCDB131 medium as a basic medium, and the following components at the working concentrations were further included: 20 mM glucose, 2% of bovine serum albumin (BSA), 1.5 g/L of sodium bicarbonate, 1×glutamine (GlutaMAX), 0.05 mM vitamin C, 1×insulin-transferrin-selenium-ethanolamine additive (ITS-X), 2 μM ALK inhibitor (K02288), 1 μM triiodothyronine (T3), 10 μM YO-01027 (Notch signaling pathway inhibitor), and 10 μM zinc sulfate, with the concentrations all being final concentrations; and the composition of the pancreatic islet β cell medium 2 was: with an MCDB131 medium as a basic medium, and the following components at the working concentrations were further included: 20 mM glucose, 2% of bovine serum albumin (BSA), 1.5 g/L of sodium bicarbonate, 1×glutamine (GlutaMAX), 0.05 mM vitamin C, 1×insulin-transferrin-selenium-ethanolamine additive (ITS-X), 1 μM triiodothyronine (T3), 10 μM Repsox (ALK5 inhibitor), 10 μM vitamin E, 10 μg/ml of heparin sodium, 2 μM R428 (Axl inhibitor), 10 μM zinc sulfate, and 10 mM N-acetyl-L-cysteine (N-cys), with the concentrations all being final concentrations.
[0056] (2) Detection of the Expression of PDX1 in the Pancreatic Progenitor Cell Stage by Means of Flow Cytometry
[0057] Adherent cells cultured on a pancreatic progenitor cell stage culture plate were washed three times with PBS free of calcium and magnesium ions (i.e., DPBS), the remaining medium was removed, the cells were covered with 0.05% of chymotrypsin-trypsin (Trypsin) and placed in an incubator at 37° C. for 10 minutes of digestion, the digestion was then terminated using DPBS containing 2% fetal bovine serum (FBS), the product was carefully pipetted to form a single cell suspension, the single cell suspension was centrifuged at 3000 rpm for 5 minutes, and the supernatant was removed to leave cell pellets; the cell pellets were resuspended with 2% FBS in DPBS, the product was carefully pipetted until uniformly mixed, and centrifuged at 3000 rpm for 5 minutes, the supernatant was removed to leave cell pellets, and the operation was repeated once again. A perforating agent in a cell transcription factor kit was prepared (prepared immediately before use, and attention should be paid to avoid light), 1 ml of the perforating agent was used for gentle pipetting, the cell pellets were resuspended, and the product was placed on ice in the dark for 40 minutes of perforation; the perforation was terminated using 1 ml of a detergent in the cell transcription factor perforation kit which was prepared in advance, then the product was centrifuged at 3000 rpm for 5 minutes, and the supernatant was removed to leave cell pellets; 1 ml of the detergent was added to the pellets to resuspend the cells, the product was centrifuged at 3000 rpm for 5 minutes, the supernatant was removed to leave cell pellets, and the operation was repeated once again. A primary antibody diluted to a working concentration with the detergent was added, and the product was placed on a rotary mixer at 4° C. overnight; the next day, the product was taken out from 4° C. and rewarmed for 30 minutes, the primary antibody was terminated using 1 ml of the detergent, then the product was centrifuged at 3000 rpm for 5 minutes, and the supernatant was removed to leave cell pellets; 1 ml of the detergent was added to the cell pellets, the product was centrifuged at 3000 rpm for 5 minutes, the supernatant was removed to leave cell pellets, and the operation was repeated once again to leave the pellets, wherein close observation was carried out each time the supernatant was aspirated, and the cell pellets should not be aspirated. A fluorescent secondary antibody diluted with the detergent was added, and the product was placed on a rotary mixer at room temperature and incubated for 2 hours; the secondary antibody was terminated using 1 ml of the detergent, then the product was centrifuged at 3000 rpm for 5 minutes, and the supernatant was removed to leave cell pellets; 1 ml of the detergent was added to the cell pellets, the product was centrifuged at 3000 rpm for 5 minutes, the supernatant was removed to leave the cell pellets, and the operation was repeated once again to leave the pellets. The cell pellets were gently pipetted using 200 μl of DPBS and transferred to a flow tube; and an FACSCelesta flow cytometric analyzer was used for sample analysis. The primary antibody used was human PDX-1/IPF1 antibody (AF2419, 1:500, RD); and the secondary antibody used in this study was donkey anti-goat PE fluorescent dye (115-035-003, 1:200, Jackson ImmunoResearch).
[0058] The expression of PDX1 in the pancreatic progenitor cell stage was detected by means of flow cytometry, and the results were as shown in
[0059] (3) Detection of the relative expression of mRNAs of PDX1 and NKX6-1 in the pancreatic progenitor cell stage and detection of the relative expression of mRNA of INS in the mature pancreatic islet β cell stage by Real-time fluorescence quantitative PCR
[0060] 1) Total RNA Extraction from Cells
[0061] Cells cultured in a 24-well plate were collected, and washed twice with 500 μl of DPBS at first, then covered with 200 μl of chymotrypsin-trypsin (Trypsin), and placed at 37° C. for 5 minutes of digestion. Whether the cells float in pieces was observed, and the digestion was terminated using 500 μl of DMEM/F12 medium, then the product was centrifuged at 1000 rpm for 3 minutes, the supernatant was removed, and cell pellets were collected and added to a new RNase-free centrifuge tube. A lysis solution in a rapid and small-amount extraction kit of total RNA was used, and 350 μl of the lysis solution was added to each tube and then uniformly mixed using a pipette (to avoid bubble generation caused by excessive pipetting), or a vortex mixer was used to break up the cells such that the cells were fully lysed; the product was centrifuged at 14,000×g for 5 minutes at room temperature; after centrifugation, the liquid was taken and added to an equal volume of an RNA binding agent in which anhydrous ethanol was added in advance, then the mixture was added to each centrifuge tube, pipetted five times with a pipette, and the liquid, which had been pipetted until uniformly mixed, was transferred to a high-purification RNA column, which was mounted in a 2 ml collection tube for 1 minute of centrifugation at 12,000×g; the filtrate was discarded, the column was placed back into the collection tube, 500 μl of kit detergent 1 was added to the column, centrifugation was performed at 12,000×g for 1 minute, the filtrate was discarded, the column was placed back into the collection tube, then 500 μl of kit detergent 2 (diluted with ethanol) was added, centrifugation was performed at 12,000×g for 1 minute, and 500 μl of kit detergent 2 was added so as to repeat the operation once again; the filtrate was discarded, and the column was placed back into the collection tube for 2 minutes of centrifugation at 12,000×g; then the column was transferred to a new 1.5 ml centrifuge tube, 50 μl of RNase-free water was added to the center of a column membrane, which was left to stand at room temperature for 2 minutes, followed by 1 minute of centrifugation at 12,000×g, and the above-mentioned operation was repeated once again to improve the RNA elution efficiency. The column was discarded and the RNA was stored in an ultra-low-temperature refrigerator at −80° C.
[0062] 2) Preparation of cDNA
[0063] The concentration and purity of the total RNA extracted above was determined (A260/A280 absorbance ratio >1.8), and a reverse transcription kit from the manufacturer Biotool was used to obtain cDNA: wherein the total RNA was taken and placed on ice, the volume required for the reverse transcription of 1 μg of RNA was calculated according to the concentration, and the corresponding volume of RNA was added; 4 μl of 5×qRT reverse transcription mix was then added, and the rest was made up with RNase-free water to obtain a total volume of 20 μl of a reverse transcription mixture liquid; and the reverse transcription mixture liquid was gently mixed, the uniformly mixed liquid was centrifuged by means of a palm centrifuge to the bottom of a 1.5 ml centrifuge tube, a common Bio-rad PCR instrument was used for reverse transcription under the reaction conditions of 25° C. for 10 min, 42° C. for 30 min and 85° C. for 5 min, and afterwards, the product was stored at −20° C.
[0064] 3) Detection of the Relative Expression of mRNAs of PDX1, NKX6-1 and INS by SYBR Green Real-Time Fluorescence Quantitative PCR
[0065] 50 ng of cDNA obtained from the above-mentioned reverse transcription was taken, 5 μl of 2×SYBR Green qPCR mixture, 5 μM of upstream primer and 5 μM of downstream primer were added, and the rest was made up with RNase-free water to a total volume of 10 μl; and CFX384 Bio-rad model quantitative PCR instrument was used for amplification under the reaction conditions of 95° C. for 5 min, 95° C. for 15 s and 60° C. for 30 s, repeated 39 cycles, 95° C. for 15 s, and ending with 65° C. for 15 s. The experimental results were analyzed using a ΔΔCT method with reference to the housekeeping gene GAPDH. Primers used in this study were: GAPDH upstream primer AATGAAGGGGTCATTGATGG, downstream primer AAGGTGAAGGTCGGA GTCAA; PDX1 upstream primer TTAGGATGTGGACGTAATTCCTGTT, downstream primer GGCCACTGT GCTTGTCTTCA; NKX6-1 upstream primer AGACCCACTTTT TCCGGACA, downstream primer CCAACGAATAGGCCAAACGA; INSMLIN upstream primer GCAGCCTTTGTGAACCAACAC, and downstream primer CCCCG CACACTAGGTAGAGA.
[0066] The relative expression of mRNAs of PDX1 and NKX6-1 in the pancreatic progenitor cell stage was detected by means of real-time fluorescent quantitative PCR, and the results were as shown in
[0067] the relative expression of mRNA of INS in the mature pancreatic islet β cell stage was detected by means of real-time fluorescent quantitative PCR, and the results were as shown in
[0068] (4) Immunofluorescence Detection of the Expression of PDX1 Protein in the Pancreatic Progenitor Cell Stage and PDX1/INS Proteins in the Mature Pancreatic Islet β Cell Stage
[0069] Cells in a culture plate were washed three times with a phosphate buffered saline (PBS), 3 minutes each time; the cells were fixed with 4% paraformaldehyde at room temperature for 20 minutes, and washed three times with PBS, 3 minutes each time; a blocking solution was prepared in advance (by adding Triton at a final concentration of 0.3% to 9 ml of DPBS, adding donkey serum at a final concentration of 10%, and uniformly mixing); the above-prepared blocking solution was used for blocking and perforation at room temperature for 2 hours; the blocking solution was soaked up, a working concentration of primary antibody prepared with the blocking solution was then added, and the product was left to stand at room temperature for 30 minutes and then placed in a refrigerator at 4° C. overnight; the next day, the product was washed three times with PBS, 3 minutes each time; a fluorescent secondary antibody of donkey serum was added and incubation was carried out at room temperature for 2 hours; in the same way, the product was washed three times with PBS, 3 minutes each time; the product was incubated with a working solution of the nuclear dye DAPI at room temperature for 10 minutes, and washed three times with PBS, 3 minutes each time; then a fluorescence microscope was used for observation and data were collected. The primary antibodies used in this study were as follows: human PDX-1/IPF1 antibody (AF2419, 1:1000, RD); Anti-PDX1 (ab47267, 1:200, Abcam); Anti-PDX1 (ab47383, 1:1000, Abcam); and insulin antibody (SC-29062, 1:100, SantaCruz). The fluorescent secondary antibodies used in this study were as follows: donkey anti-goat TRITC fluorescent dye (705-025-147, 1:200, Jackson ImmunoResearch); donkey anti-goat FITC fluorescent dye (705-095-003, 1:200, Jackson ImmunoResearch); donkey anti-goat 488 fluorescent dye (705-545-147, 1:200, Jackson ImmunoResearch); donkey anti-rabbit TRITC fluorescent dye (711-025-152, 1:200, Jackson ImmunoResearch); donkey anti-rabbit 488 fluorescent dye (705-095-152, 1:200, Jackson ImmunoResearch); donkey anti-mouse FITC fluorescent dye (715-095-150, 1:200, Jackson ImmunoResearch); and nuclear dye DAPI (Roche, USA).
[0070] The expression of PDX1 protein in the pancreatic progenitor cell stage was detected by means of immunofluorescence, and the results were as shown in
[0071] The expression of PDX1/INS proteins in the mature pancreatic islet β cell stage was detected by means of immunofluorescence, and the results were as shown in
[0072] The results showed that the adding of the staged WNT signaling pathway inhibitor provided by the present disclosure could greatly increase the number of mature pancreatic islet β cells.
Example 2 Differentiation of Human Embryonic Stem Cells into Pancreatic Progenitor Cells and Pancreatic Islet β Cells by Induction of the WNT Signaling Pathway Inhibitor IWR-1
[0073] (1) Cell Differentiation
[0074] 1) Differentiation of Human Embryonic Stem Cells into Definitive Endoderm Cells:
[0075] a. definitive endoderm stage medium 1 was prepared, and the human embryonic stem cells were cultured in the medium in a carbon dioxide incubator at 37 degrees Celsius for 1 day; and
[0076] b. definitive endoderm stage medium 2 was prepared, the definitive endoderm stage medium 1 in above-mentioned step a was replaced with the definitive endoderm stage medium 2, and the cells were cultured in a carbon dioxide incubator at 37 degrees Celsius for 3 days, during which the medium was replaced every day, wherein the composition of the definitive endoderm stage medium 1 was: a basic medium was prepared by mixing an IMDM medium and an F12 medium at a ratio of 1:1, and the following components at the working concentrations were further included: 0.2% of bovine serum albumin (BSA), 1% of penicillin, 1% of streptomycin, 100 ng/ml of recombinant human activin-A (Activin A), and 50 ng/ml of Wnt3a protein, with the concentrations all being final concentrations; and the composition of the definitive endoderm stage medium 2 was: a basic medium was prepared by mixing an IMDM medium and an F12 medium at a ratio of 1:1, and the following components at the working concentrations were further included: 0.2% of bovine serum albumin (BSA), 1% of penicillin, 1% of streptomycin, and 100 ng/ml of recombinant human activin-A (Activin A), with the concentrations all being final concentrations.
[0077] 2) Induction of the Differentiation of Definitive Endoderm Cells into Pancreatic Progenitor Cells:
[0078] a pancreatic progenitor cell medium was prepared, the medium in step 1) was replaced with the pancreatic progenitor cell medium, and the cells were cultured in a carbon dioxide incubator at 37 degrees Celsius for 5 days, during which the medium was replaced every day, wherein the composition of the pancreatic progenitor cell medium was: with an MCDB131 medium as a basic medium, and the following components at the working concentrations were further included: 0.5% of bovine serum albumin (BSA), 1.5 g/L of sodium bicarbonate, 1×glutamine (GlutaMAX), 10 mM glucose, 0.25 M vitamin C, 1×insulin-transferrin-selenium-ethanolamine additive (ITS-X), 50 ng/ml of fibroblast growth factor 7 (KGF), 0.5 μM SANT1 (with smo as an inhibitor target), 100 nM retinoic acid (TTNPB), 500 nM phorbol 12,13-dibutyrate (PDBu), 2 μM ALK inhibitor (K02288), and 2 μM WNT signaling pathway inhibitor IWR-1 (not added in a control group), with the concentrations all being final concentrations.
[0079] 3) Further Differentiation of Pancreatic Progenitor Cells to Obtain Pancreatic Islet β Cells:
[0080] a. pancreatic islet β cell medium 1 was prepared, the medium in step 2) was replaced with the pancreatic islet β cell medium 1, and the cells were cultured in a carbon dioxide incubator at 37 degrees Celsius for 5 days, during which the medium was replaced every day; and
[0081] b. pancreatic islet β cell medium 2 was prepared, the pancreatic islet β cell medium 1 in above-mentioned step a was replaced with the pancreatic islet β cell medium 2, and the cells were cultured in a carbon dioxide incubator at 37 degrees Celsius for 5 days, during which the medium was replaced every day, wherein the composition of the pancreatic islet β cell medium 1 was: with an MCDB131 medium as a basic medium, and the following components at the working concentrations were further included: 20 mM glucose, 2% of bovine serum albumin (BSA), 1.5 g/L of sodium bicarbonate, 1×glutamine (GlutaMAX), 0.05 mM vitamin C, 1×insulin-transferrin-selenium-ethanolamine additive (ITS-X), 2 μM ALK inhibitor (K02288), 1 μM triiodothyronine (T3), 10 μM YO-01027 (Notch signaling pathway inhibitor), and 10 μM zinc sulfate, with the concentrations all being final concentrations; and the composition of the pancreatic islet β cell medium 2 was: with an MCDB131 medium as a basic medium, and the following components at the working concentrations were further included: 20 mM glucose, 2% of bovine serum albumin (BSA), 1.5 g/L of sodium bicarbonate, 1×glutamine (GlutaMAX), 0.05 mM vitamin C, 1×insulin-transferrin-selenium-ethanolamine additive (ITS-X), 1 μM triiodothyronine (T3), 10 μM Repsox (ALK5 inhibitor), 10 μM vitamin E, 10 μg/ml of heparin sodium, 2 μM R428 (Axl inhibitor), 10 μM zinc sulfate, and 10 mM N-acetyl-L-cysteine (N-cys), with the concentrations all being final concentrations.
[0082] (2) Detection of the Expression of PDX1 in the Pancreatic Progenitor Cell Stage by Means of Flow Cytometry
[0083] Adherent cells cultured on a pancreatic progenitor cell stage culture plate were washed three times with PBS free of calcium and magnesium ions (i.e., DPBS), the remaining medium was removed, the cells were covered with 0.05% of chymotrypsin-trypsin (Trypsin) and placed in an incubator at 37° C. for 10 minutes of digestion, the digestion was then terminated using DPBS containing 2% fetal bovine serum (FBS), the product was carefully pipetted to form a single cell suspension, the single cell suspension was centrifuged at 3000 rpm for 5 minutes, and the supernatant was removed to leave cell pellets; the cell pellets were resuspended with 2% FBS in DPBS, the product was carefully pipetted until uniformly mixed, and centrifuged at 3000 rpm for 5 minutes, the supernatant was removed to leave cell pellets, and the operation was repeated once again. A perforating agent in a cell transcription factor kit was prepared (prepared immediately before use, and attention should be paid to avoid light), 1 ml of the perforating agent was used for gentle pipetting, the cell pellets were resuspended, and the product was placed on ice in the dark for 40 minutes of perforation; the perforation was terminated using 1 ml of a detergent in the cell transcription factor perforation kit which was prepared in advance, then the product was centrifuged at 3000 rpm for 5 minutes, and the supernatant was removed to leave cell pellets; 1 ml of the detergent was added to the pellets to resuspend the cells, the product was centrifuged at 3000 rpm for 5 minutes, the supernatant was removed to leave cell pellets, and the operation was repeated once again. A primary antibody diluted to a working concentration with the detergent was added, and the product was placed on a rotary mixer at 4° C. overnight; the next day, the product was taken out from 4° C. and rewarmed for 30 minutes, the primary antibody was terminated using 1 ml of the detergent, then the product was centrifuged at 3000 rpm for 5 minutes, and the supernatant was removed to leave cell pellets; 1 ml of the detergent was added to the cell pellets, the product was centrifuged at 3000 rpm for 5 minutes, the supernatant was removed to leave cell pellets, and the operation was repeated once again to leave the pellets, wherein close observation was carried out each time the supernatant was aspirated, and the cell pellets should not be aspirated. A fluorescent secondary antibody diluted with the detergent was added, and the product was placed on a rotary mixer at room temperature and incubated for 2 hours; the secondary antibody was terminated using 1 ml of the detergent, then the product was centrifuged at 3000 rpm for 5 minutes, and the supernatant was removed to leave cell pellets; 1 ml of the detergent was added to the cell pellets, the product was centrifuged at 3000 rpm for 5 minutes, the supernatant was removed to leave cell pellets, and the operation was repeated once again to leave the pellets; The cell pellets were gently pipetted using 200 μl of DPBS and transferred to a flow tube; and an FACSCelesta flow cytometric analyzer was used for sample analysis. The primary antibody used was human PDX-1/IPF1 antibody (AF2419, 1:500, RD); and the secondary antibody used in this study was donkey anti-goat PE fluorescent dye (115-035-003, 1:200, Jackson ImmunoResearch).
[0084] The expression of PDX1 in the pancreatic progenitor cell stage was detected by means of flow cytometry, and the results were as shown in
[0085] (3) Detection of the Relative Expression of mRNAs of PDX1 and NKX6-1 in the Pancreatic Progenitor Cell Stage and Detection of the Relative Expression of mRNA of INS in the Mature Pancreatic Islet β Cell Stage by Real-Time Fluorescence Quantitative PCR
[0086] 1) Total RNA Extraction from Cells
[0087] Cells cultured in a 24-well plate were collected, and washed twice with 500 μl of DPBS at first, then covered with 200 μl of chymotrypsin-trypsin (Trypsin), and placed at 37° C. for 5 minutes of digestion. Whether the cells float in pieces was observed, and the digestion was terminated using 500 μl of DMEM/F12 medium, then the product was centrifuged at 1000 rpm for 3 minutes, the supernatant was removed, and cell pellets were collected and added to a new RNase-free centrifuge tube. A lysis solution in a rapid and small-amount extraction kit of total RNA was used, and 350 μl of the lysis solution was added to each tube and then uniformly mixed using a pipette (to avoid bubble generation caused by excessive pipetting), or a vortex mixer was used to break up the cells such that the cells were fully lysed; the product was centrifuged at 14,000×g for 5 minutes at room temperature; after centrifugation, a liquid was taken and added to an equal volume of an RNA binding agent in which anhydrous ethanol was added in advance, the mixture was added to each centrifuge tube, pipetted five times with a pipette, and the liquid, which had been pipetted until uniformly mixed, was transferred to a high-purification RNA column, which was mounted in a 2 ml collection tube for 1 minute of centrifugation at 12,000×g; the filtrate was discarded, the column was placed back into the collection tube, 500 μl of kit detergent 1 was added to the column, centrifugation was performed at 12,000×g for 1 minute, the filtrate was discarded, the column was placed back into the collection tube, then 500 μl of kit detergent 2 (diluted with ethanol) was added, centrifugation was performed at 12,000×g for 1 minute, and 500 μl of kit detergent 2 was added so as to repeat the operation once again; the filtrate was discarded, and the column was placed back into the collection tube for 2 minutes of centrifugation at 12,000×g; then the column was transferred to a new 1.5 ml centrifuge tube, 50 μl of RNase-free water was added to the center of a column membrane, which was left to stand at room temperature for 2 minutes, followed by 1 minute of centrifugation at 12,000×g, and the above-mentioned operation was repeated once again to improve the RNA elution efficiency. The column was discarded and the RNA was stored in an ultra-low-temperature refrigerator at −80° C.
[0088] 2) Preparation of cDNA
[0089] The concentration and purity of the total RNA extracted above was determined (A260/A280 absorbance ratio >1.8), and a reverse transcription kit from the manufacturer Biotool was used to obtain cDNA, wherein the total RNA was taken and placed on ice, the volume required for the reverse transcription of 1 μg of RNA was calculated according to the concentration, and the corresponding volume of RNA was added; 4 μl of 5×qRT reverse transcription mix was then added, and the rest was made up with RNase-free water to obtain a total volume of 20 μl of a reverse transcription mixture liquid; and the reverse transcription mixture liquid was gently mixed, the uniformly mixed liquid was centrifuged by means of a palm centrifuge to the bottom of a 1.5 ml centrifuge tube, a common Bio-rad PCR instrument was used for reverse transcription under the reaction conditions of 25° C. for 10 min, 42° C. for 30 min and 85° C. for 5 min, and afterwards, the product was stored at −20° C.
[0090] 3) Detection of the Relative Expression of mRNAs of PDX1, NKX6-1 and INS by SYBR Green Real-Time Fluorescence Quantitative PCR
[0091] 50 ng of cDNA obtained from the above-mentioned reverse transcription was taken, 5 μl of 2×SYBR Green qPCR mixture, 5 μM of upstream primer and 5 μM of downstream primer were added, and the rest was made up with RNase-free water to a total volume of 10 μl; and CFX384 Bio-rad model quantitative PCR instrument was used for amplification under the reaction conditions of 95° C. for 5 min, 95° C. for 15 s and 60° C. for 30 s, repeated 39 cycles, 95° C. for 15 s, and ending with 65° C. for 15 s. The experimental results were analyzed using a ΔΔCT method with reference to the housekeeping gene GAPDH. Primers used in this study were: GAPDH upstream primer AATGAAGGGGTCATTGATGG, downstream primer AAGGTGAAGGTCGGA GTCAA; PDX1 upstream primer TTAGGATGTGGACGTAATTCCTGTT, downstream primer GGCCACTGT GCTTGTCTTCA; NKX6-1 upstream primer AGACCCACTTTT TCCGGACA, downstream primer CCAACGAATAGGCCAAACGA; INSMLIN upstream primer GCAGCCTTTGTGAACCAACAC, and downstream primer CCCCG CACACTAGGTAGAGA.
[0092] The relative expression of mRNAs of PDX1 and NKX6-1 in the pancreatic progenitor cell stage was detected by means of real-time fluorescent quantitative PCR, and the results were as shown in
[0093] (4) Immunofluorescence Detection of the Expression of PDX1 Protein in the Pancreatic Progenitor Cell Stage and PDX1/INS Proteins in the Mature Pancreatic Islet β Cell Stage
[0094] Cells in a culture plate were washed three times with a phosphate buffered saline (PBS), 3 minutes each time; the cells were fixed with 4% paraformaldehyde at room temperature for 20 minutes, and washed three times with PBS, 3 minutes each time; a blocking solution was prepared in advance (by adding Triton at a final concentration of 0.3% to 9 ml of DPBS, adding donkey serum at a final concentration of 10%, and uniformly mixing); the above-prepared blocking solution was used for blocking and perforation at room temperature for 2 hours; the blocking solution was soaked up, a working concentration of primary antibody prepared with the blocking solution was then added, and the product was left to stand at room temperature for 30 minutes and then placed in a refrigerator at 4° C. overnight; the next day, the product was washed three times with PBS, 3 minutes each time; a fluorescent secondary antibody of donkey serum was added and incubation was carried out at room temperature for 2 hours; in the same way, the product was washed three times with PBS, 3 minutes each time; the product was incubated with a working solution of the nuclear dye DAPI at room temperature for 10 minutes, and washed three times with PBS, 3 minutes each time; then a fluorescence microscope was used for observation and data were collected. The primary antibodies used in this study were as follows: human PDX-1/IPF1 antibody (AF2419, 1:1000, RD); Anti-PDX1 (ab47267, 1:200, Abcam); Anti-PDX1 (ab47383, 1:1000, Abcam); and insulin antibody (SC-29062, 1:100, SantaCruz). The fluorescent secondary antibodies used in this study were donkey anti-goat TRITC fluorescent dye (705-025-147, 1:200, Jackson ImmunoResearch); donkey anti-goat FITC fluorescent dye (705-095-003, 1:200, Jackson ImmunoResearch); donkey anti-goat 488 fluorescent dye (705-545-147, 1:200, Jackson ImmunoResearch); donkey anti-rabbit TRITC fluorescent dye (711-025-152, 1:200, Jackson ImmunoResearch); donkey anti-rabbit 488 fluorescent dye (705-095-152, 1:200, Jackson ImmunoResearch); donkey anti-mouse FITC fluorescent dye (715-095-150, 1:200, Jackson ImmunoResearch); and nuclear dye DAPI (Roche, USA).
[0095] The expression of PDX1 protein in the pancreatic progenitor cell stage was detected by means of immunofluorescence, and the results were as shown in
[0096] The expression of PDX1/INS proteins in the mature pancreatic islet β cell stage was detected by means of immunofluorescence, and the results were as shown in
[0097] The results showed that the adding of the staged WNT signaling pathway inhibitor provided by the present disclosure could greatly increase the number of mature pancreatic islet β cells.
Example 3 Differentiation of Human Induced Pluripotent Stem Cells into Pancreatic Progenitor Cells and Mature Pancreatic Islet β Cells by Induction of the WNT Signaling Pathway Inhibitor XAV-939
[0098] (1) Cell Differentiation
[0099] 1) Differentiation of Human Induced Pluripotent Stem Cells into Definitive Endoderm Cells:
[0100] a. definitive endoderm stage medium 1 was prepared, and the human induced pluripotent stem cells were cultured in the medium in a carbon dioxide incubator at 37 degrees Celsius for 1 day; and
[0101] b. definitive endoderm stage medium 2 was prepared, the definitive endoderm stage medium 1 in above-mentioned step a was replaced with the definitive endoderm stage medium 2, and the cells were cultured in a carbon dioxide incubator at 37 degrees Celsius for 3 days, during which the medium was replaced every day, wherein the composition of the definitive endoderm stage medium 1 was: a basic medium was prepared by mixing an IMDM medium and an F12 medium at a ratio of 1:1, and the following components at the working concentrations were further included: 0.2% of bovine serum albumin (BSA), 1% of penicillin, 1% of streptomycin, 100 ng/ml of recombinant human activin-A (Activin A), and 50 ng/ml of Wnt3a protein, with the concentrations all being final concentrations; and the composition of the definitive endoderm stage medium 2 was: a basic medium was prepared by mixing an IMDM medium and an F12 medium at a ratio of 1:1, and the following components at the working concentrations were further included: 0.2% of bovine serum albumin (BSA), 1% of penicillin, 1% of streptomycin, and 100 ng/ml of recombinant human activin-A (Activin A), with the concentrations all being final concentrations.
[0102] 2) Induction of the Differentiation of Definitive Endoderm Cells into Pancreatic Progenitor Cells:
[0103] a pancreatic progenitor cell medium was prepared, the medium in step 1) was replaced with the pancreatic progenitor cell medium, and the cells were cultured in a carbon dioxide incubator at 37 degrees Celsius for 5 days, during which the medium was replaced every day, wherein the composition of the pancreatic progenitor cell medium was: with an MCDB131 medium as a basic medium, and the following components at the working concentrations were further included: 0.5% of bovine serum albumin (BSA), 1.5 g/L of sodium bicarbonate, 1×glutamine (GlutaMAX), 10 mM glucose, 0.25 M vitamin C, 1×insulin-transferrin-selenium-ethanolamine additive (ITS-X), 50 ng/ml of fibroblast growth factor (KGF), 0.5 μM SANT1 (with smo as an inhibitor target), 100 nM retinoic acid (TTNPB), 500 nM phorbol 12,13-dibutyrate (PDBu), 2 μM ALK inhibitor (K02288), and 2 μM WNT signaling pathway inhibitor XAV-939 (not added in a control group), with the concentrations all being final concentrations.
[0104] 3) Further Differentiation of Pancreatic Progenitor Cells to Obtain Pancreatic Islet β Cells:
[0105] a. pancreatic islet β cell medium 1 was prepared, the medium in step 2) was replaced with the pancreatic islet β cell medium 1, and the cells were cultured in a carbon dioxide incubator at 37 degrees Celsius for 5 days, during which the medium was replaced every day; and
[0106] b. pancreatic islet β cell medium 2 was prepared, the pancreatic islet β cell medium 1 in above-mentioned step a was replaced with the pancreatic islet β cell medium 2, and the cells were cultured in a carbon dioxide incubator at 37 degrees Celsius for 5 days, during which the medium was replaced every day, wherein the composition of the pancreatic islet β cell medium 1 was: with an MCDB131 medium as a basic medium, and the following components at the working concentrations were further included: 20 mM glucose, 2% of bovine serum albumin (BSA), 1.5 g/L of sodium bicarbonate, 1×glutamine (GlutaMAX), 0.05 mM vitamin C, 1×insulin-transferrin-selenium-ethanolamine additive (ITS-X), 2 μM ALK inhibitor (K02288), 1 μM triiodothyronine (T3), 10 μM YO-01027 (Notch signaling pathway inhibitor), and 10 μM zinc sulfate, with the concentrations all being final concentrations; and the composition of the pancreatic islet β cell medium 2 was: with an MCDB131 medium as a basic medium, and the following components at the working concentrations were further included: 20 mM glucose, 2% of bovine serum albumin (BSA), 1.5 g/L of sodium bicarbonate, 1×glutamine (GlutaMAX), 0.05 mM vitamin C, 1×insulin-transferrin-selenium-ethanolamine additive (ITS-X), 1 μM triiodothyronine (T3), 10 μM Repsox (ALK5 inhibitor), 10 μM vitamin E, 10 μg/ml of heparin sodium, 2 μM R428 (Axl inhibitor), 10 μM zinc sulfate, and 10 mM N-acetyl-L-cysteine (N-cys), with the concentrations all being final concentrations.
[0107] (2) Detection of the Expression of PDX1 in the Pancreatic Progenitor Cell Stage by Means of Flow Cytometry
[0108] Adherent cells cultured on a pancreatic progenitor cell stage culture plate were washed three times with PBS free of calcium and magnesium ions (i.e., DPBS), the remaining medium was removed, the cells were covered with 0.05% of chymotrypsin-trypsin (Trypsin) and placed in an incubator at 37° C. for 10 minutes of digestion, the digestion was then terminated using DPBS containing 2% fetal bovine serum (FBS), the product was carefully pipetted to form a single cell suspension, the single cell suspension was centrifuged at 3000 rpm for 5 minutes, and the supernatant was removed to leave cell pellets; the cell pellets were resuspended with 2% FBS in DPBS, the product was carefully pipetted until uniformly mixed, and centrifuged at 3000 rpm for 5 minutes, the supernatant was removed to leave cell pellets, and the operation was repeated once again. A perforating agent in a cell transcription factor kit was prepared (prepared immediately before use, and attention should be paid to avoid light), 1 ml of the perforating agent was used for gentle pipetting, the cell pellets were resuspended, and the product was placed on ice in the dark for 40 minutes of perforation; the perforation was terminated using 1 ml of a detergent in the cell transcription factor perforation kit which was prepared in advance, then the product was centrifuged at 3000 rpm for 5 minutes, and the supernatant was removed to leave cell pellets; 1 ml of the detergent was added to the pellets to resuspend the cells, the product was centrifuged at 3000 rpm for 5 minutes, the supernatant was removed to leave cell pellets, and the operation was repeated once again. A primary antibody diluted to a working concentration with the detergent was added, and the product was placed on a rotary mixer at 4° C. overnight; the next day, the product was taken out from 4° C. and rewarmed for 30 minutes, the primary antibody was terminated using 1 ml of the detergent, then the product was centrifuged at 3000 rpm for 5 minutes, and the supernatant was removed to leave cell pellets; 1 ml of the detergent was added to the cell pellet, the product was centrifuged at 3000 rpm for 5 minutes, the supernatant was removed to leave cell pellets, and the operation was repeated once again to leave the pellets, wherein close observation was carried out each time the supernatant was aspirated, and the cell pellets should not be aspirated. A fluorescent secondary antibody diluted with the detergent was added, and the product was placed on a rotary mixer at room temperature and incubated for 2 hours; the secondary antibody was terminated using 1 ml of the detergent, then the product was centrifuged at 3000 rpm for 5 minutes, and the supernatant was removed to leave cell pellets; 1 ml of the detergent was added to the cell pellets, the product was centrifuged at 3000 rpm for 5 minutes, the supernatant was removed to leave cell pellets, and the operation was repeated once again to leave the pellets. The cell pellets were gently pipetted using 200 μl of DPBS and transferred to a flow tube; and an FACSCelesta flow cytometric analyzer was used for sample analysis. The primary antibody used in this study was human PDX-1/IPF1 antibody (AF2419, 1:500, RD); and the secondary antibody used in this study was donkey anti-goat PE fluorescent dye (115-035-003, 1:200, Jackson ImmunoResearch).
[0109] The expression of PDX1 in the pancreatic progenitor cell stage was detected by means of flow cytometry, and the results were as shown in
[0110] (3) Detection of the Relative Expression of mRNAs of PDX1 and NKX6-1 in the Pancreatic Progenitor Cell Stage and Detection of the Relative Expression of mRNA of INS in the Mature Pancreatic Islet β Cell Stage by Real-Time Fluorescence Quantitative PCR
[0111] 1) Total RNA Extraction from Cells
[0112] Cells cultured in a 24-well plate were collected, and washed twice with 500 μl of DPBS, at first, then covered with 200 μl of chymotrypsin-trypsin (Trypsin), and placed at 37° C. for 5 minutes of digestion. Whether the cells float in pieces was observed, and the digestion was terminated using 500 μl of DMEM/F12 medium, then the product was centrifuged at 1000 rpm for 3 minutes, the supernatant was removed, and cell pellets were collected and added to a new RNase-free centrifuge tube. A lysis solution in a rapid and small-amount extraction kit of total RNA was used, and 350 μl of the lysis solution was added to each tube and then uniformly mixed using a pipette (to avoid bubble generation caused by excessive pipetting), or a vortex mixer was used to break up the cells such that the cells were fully lysed; the product was centrifuged at 14,000×g for 5 minutes at room temperature; after centrifugation, the liquid was taken and added to an equal volume of an RNA binding agent in which anhydrous ethanol was added in advance, then the mixture was added to each centrifuge tube, pipetted five times with a pipette, and the liquid, which had been pipetted until uniformly mixed, was transferred to a high-purification RNA column, which was mounted in a 2 ml collection tube for 1 minute of centrifugation at 12,000×g; the filtrate was discarded, the column was placed back into the collection tube, 500 μl of kit detergent 1 was added to the column, centrifugation was performed at 12,000×g for 1 minute, the filtrate was discarded, the column was placed back into the collection tube, then 500 μl of kit detergent 2 (diluted with ethanol) was added, centrifugation was performed at 12,000×g for 1 minute, and 500 μl of kit detergent 2 was added so as to repeat the operation once again; the filtrate was discarded, and the column was placed back into the collection tube for 2 minutes of centrifugation at 12,000×g; then the column was transferred to a new 1.5 ml centrifuge tube, 50 μl of RNase-free water was added to the center of a column membrane, which was left to stand at room temperature for 2 minutes, followed by 1 minute of centrifugation at 12,000×g, and the above-mentioned operation was repeated once again to improve the RNA elution efficiency. The column was discarded and the RNA was stored in an ultra-low-temperature refrigerator at −80° C.
[0113] 2) Preparation of cDNA
[0114] The concentration and purity of the total RNA extracted above was determined (A260/A280 absorbance ratio >1.8), and a reverse transcription kit from the manufacturer Biotool was used to obtain cDNA, wherein the total RNA was taken and placed on ice, the volume required for the reverse transcription of 1 μg of RNA was calculated according to the concentration, and the corresponding volume of RNA was added; 4 μl of 5×qRT reverse transcription mix was then added, and the rest was made up with RNase-free water to obtain a total volume of 20 μl of a reverse transcription mixture liquid; and the reverse transcription mixture liquid was gently mixed, the uniformly mixed liquid was centrifuged by means of a palm centrifuge to the bottom of a 1.5 ml centrifuge tube, a common Bio-rad PCR instrument was used for reverse transcription under the reaction conditions of 25° C. for 10 min, 42° C. for 30 min and 85° C. for 5 min, and afterwards, the product was stored at −20° C.
[0115] 3) Detection of the Relative Expression of mRNAs of PDX1, NKX6-1 and INS by SYBR Green Real-Time Fluorescence Quantitative PCR
[0116] 50 ng of cDNA obtained from the above-mentioned reverse transcription was taken, 5 μl of 2×SYBR Green qPCR mixture, 5 μM of upstream primer and 5 μM of downstream primer were added, and the rest was made up with RNase-free water to a total volume of 10 μl; and CFX384 Bio-rad model quantitative PCR instrument was used for amplification under the reaction conditions of 95° C. for 5 min, 95° C. for 15 s and 60° C. for 30 s, repeated 39 cycles, 95° C. for 15 s, and ending with 65° C. for 15 s. The experimental results were analyzed using a ΔΔCT method with reference to the housekeeping gene GAPDH. Primers used in this study were: GAPDH upstream primer AATGAAGGGGTCATTGATGG, downstream primer AAGGTGAAGGTCGGA GTCAA; PDX1 upstream primer TTAGGATGTGGACGTAATTCCTGTT, downstream primer GGCCACTGT GCTTGTCTTCA; NKX6-1 upstream primer AGACCCACTTTT TCCGGACA, downstream primer CCAACGAATAGGCCAAACGA; INSMLIN upstream primer GCAGCCTTTGTGAACCAACAC, and downstream primer CCCCG CACACTAGGTAGAGA.
[0117] The relative expression of mRNAs of PDX1 and NKX6-1 in the pancreatic progenitor cell stage was detected by means of real-time fluorescent quantitative PCR, and the results were as shown in
[0118] (4) Immunofluorescence detection of the expression of PDX1 protein in the pancreatic progenitor cell stage and PDX1/INS proteins in the mature pancreatic islet β cell stage
[0119] Cells in a culture plate were washed three times with a phosphate buffered saline (PBS), 3 minutes each time; the cells were fixed with 4% paraformaldehyde at room temperature for 20 minutes, and washed three times with PBS, 3 minutes each time; a blocking solution was prepared in advance (by adding Triton at a final concentration of 0.3% to 9 ml of DPBS, adding donkey serum at a final concentration of 10%, and uniformly mixing); the above-prepared blocking solution was used for blocking and perforation at room temperature for 2 hours; the blocking solution was soaked up, a working concentration of primary antibody prepared with the blocking solution was then added, and the product was left to stand at room temperature for 30 minutes and then placed in a refrigerator at 4° C. overnight; the next day, the product was washed three times with PBS, 3 minutes each time; a fluorescent secondary antibody of donkey serum was added and incubation was carried out at room temperature for 2 hours; in the same way, the product was washed three times with PBS, 3 minutes each time; the product was incubated with a working solution of the nuclear dye DAPI at room temperature for 10 minutes, and washed three times with PBS, 3 minutes each time; then a fluorescence microscope was used for observation and data were collected. The primary antibodies used in this study were as follows: human PDX-1/IPF1 antibody (AF2419, 1:1000, RD); Anti-PDX1 (ab47267, 1:200, Abcam); Anti-PDX1 (ab47383, 1:1000, Abcam); and insulin antibody (SC-29062, 1:100, SantaCruz). The fluorescent secondary antibodies used in this study were donkey anti-goat TRITC fluorescent dye (705-025-147, 1:200, Jackson ImmunoResearch); donkey anti-goat FITC fluorescent dye (705-095-003, 1:200, Jackson ImmunoResearch); donkey anti-goat 488 fluorescent dye (705-545-147, 1:200, Jackson ImmunoResearch); donkey anti-rabbit TRITC fluorescent dye (711-025-152, 1:200, Jackson ImmunoResearch); donkey anti-rabbit 488 fluorescent dye (705-095-152, 1:200, Jackson ImmunoResearch); donkey anti-mouse FITC fluorescent dye (715-095-150, 1:200, Jackson ImmunoResearch); and nuclear dye DAPI (Roche, USA).
[0120] The expression of PDX1 protein in the pancreatic progenitor cell stage was detected by means of immunofluorescence, and the results were as shown in
[0121] The expression of PDX1/INS proteins in the mature pancreatic islet β cell stage was detected by means of immunofluorescence, and the results were as shown in
[0122] The results showed that the adding of the staged WNT signaling pathway inhibitor provided by the present disclosure could greatly increase the number of mature pancreatic islet β cells.